Accidentally taking a double dose of Ozempic (semaglutide) can be concerning, but serious complications are uncommon with prompt action. Ozempic is a GLP-1 receptor agonist used for type 2 diabetes management. If you've administered twice your prescribed dose, contact NHS 111 or your GP immediately for personalised advice. Monitor your blood glucose levels closely, watch for symptoms such as nausea, vomiting, or low blood sugar, and do not take your next scheduled dose until advised by a healthcare professional. This guide explains what to do, which symptoms to watch for, and when to seek urgent medical help.

What to Do If You Take a Double Dose of Ozempic

If you have accidentally administered a double dose of Ozempic (semaglutide), it is important to remain calm and take appropriate steps to manage the situation safely. Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist prescribed for type 2 diabetes management, and whilst an accidental overdose can cause unpleasant symptoms, serious complications are relatively uncommon when prompt action is taken.

The first step is to contact your GP surgery or NHS 111 immediately to report the incident and receive personalised guidance. Do not take any further semaglutide until you have received clinical advice. You may be advised to delay or skip your next scheduled dose, depending on your individual circumstances and medical history.

Whilst waiting for medical advice, monitor your blood glucose levels more frequently, especially if you also take insulin or sulfonylureas. If you experience hypoglycaemia (low blood sugar), take 15-20g of fast-acting carbohydrate (such as glucose tablets, fruit juice, or sugary drinks), recheck your glucose after 15 minutes, and repeat if necessary. Follow with a starchy snack once your glucose has stabilised.

Keep easily digestible foods and fluids available, and avoid operating machinery or driving if you feel unwell. If you experience severe symptoms such as persistent vomiting, severe abdominal pain, signs of dehydration, or symptoms of hypoglycaemia that do not improve with food intake, seek urgent medical attention by calling 999 or attending your nearest Accident and Emergency department.

It is helpful to note the exact dose you administered, the time of administration, and when your last regular dose was given. This information will assist healthcare professionals in assessing your risk and providing appropriate management. Keep the Ozempic pen and packaging available for reference, as this contains important information about the medication strength and batch number. Any adverse effects should be reported through the MHRA Yellow Card scheme.

Symptoms and Side Effects of Ozempic Overdose

Taking a double dose of Ozempic can lead to an exaggeration of the medication's known side effects, with gastrointestinal symptoms being the most frequently reported. Nausea is typically the earliest and most common symptom, which may range from mild queasiness to severe nausea requiring antiemetic medication. Vomiting may follow, and in cases of significant overdose, this can be persistent and lead to dehydration and electrolyte imbalances. Diarrhoea, abdominal pain, and reduced appetite are also commonly reported, reflecting the medication's effect on gastrointestinal motility and gastric emptying.

Hypoglycaemia represents another important concern, particularly in patients taking Ozempic alongside other glucose-lowering medications such as sulphonylureas or insulin. Semaglutide itself has a relatively low intrinsic risk of causing hypoglycaemia when used as monotherapy, as its glucose-lowering effect is glucose-dependent. However, an excessive dose may increase this risk. Symptoms of hypoglycaemia include trembling, sweating, confusion, palpitations, hunger, irritability, and in severe cases, loss of consciousness or seizures. Patients should be vigilant for these symptoms for several days following the accidental double dose, due to semaglutide's long half-life.

Other potential effects include dizziness, fatigue, and headache. Some individuals may experience increased heart rate, though this is typically small and of limited clinical relevance. Acute pancreatitis has been reported with GLP-1 receptor agonists and is listed in the Ozempic SmPC as a known risk. It is characterised by severe, persistent abdominal pain that may radiate to the back, often accompanied by nausea and vomiting. If pancreatitis is suspected, seek urgent medical assessment and discontinue the medication. The severity and duration of symptoms can vary considerably depending on individual factors including body weight, renal function, concurrent medications, and the specific dose administered.

Understanding Ozempic Dosing and Safety Guidelines

Ozempic is administered as a once-weekly subcutaneous injection, with a carefully structured dosing schedule designed to optimise efficacy whilst minimising adverse effects. The standard initiation regimen begins with 0.25 mg once weekly for four weeks, which serves primarily as a dose escalation phase to improve gastrointestinal tolerability rather than to achieve glycaemic control. After this period, the dose is increased to 0.5 mg once weekly, which is the minimum effective maintenance dose for most patients. Depending on individual glycaemic response and tolerability, the dose may be further increased to 1 mg once weekly after at least four weeks at the 0.5 mg dose. For patients requiring additional glycaemic control, the dose may be increased to the maximum licensed dose of 2 mg once weekly after at least four weeks at the 1 mg dose, as per the UK SmPC.

The pharmacokinetic profile of semaglutide contributes to its once-weekly dosing convenience but also has implications for overdose scenarios. Semaglutide is highly protein-bound and has a long half-life of approximately one week, meaning it takes several weeks to reach steady-state concentrations and similarly takes time to be eliminated from the body. This extended half-life means that effects of an overdose may be prolonged, with symptoms potentially persisting for several days. Semaglutide is metabolised by proteolysis and beta-oxidation, with elimination of metabolites occurring via urine and faeces. There is no specific antidote available for semaglutide overdose.

To prevent accidental double dosing, patients should establish a consistent routine for their weekly injection, ideally on the same day each week. Using a medication diary, smartphone reminder, or marking a calendar can help track doses. If you miss a dose, it should be administered as soon as possible within 5 days after the missed dose. If more than 5 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. The Ozempic pen is designed with a dose counter to show the selected dose before injection, and patients should always verify this before administering. Proper storage of the pen, keeping it out of reach of children, and ensuring only one person uses each pen are additional important safety measures as outlined in the MHRA/EMC SmPC.

When to Seek Medical Help After Taking Too Much Ozempic

Determining when to seek medical help after an accidental double dose of Ozempic depends on the severity of symptoms and individual risk factors. All patients who have taken a double dose should contact NHS 111 or their GP surgery for advice, even if they feel well initially, as symptoms may develop or worsen over the subsequent hours. This is particularly important for individuals with additional risk factors such as renal impairment, elderly patients, those taking multiple glucose-lowering medications, or anyone with a history of gastrointestinal disorders or pancreatitis.

If you are pregnant, planning pregnancy, or breastfeeding, seek urgent medical advice as semaglutide is not recommended during pregnancy or breastfeeding according to the SmPC. Healthcare professionals managing overdose cases can access specialist advice through the National Poisons Information Service (NPIS) or TOXBASE.

Immediate emergency medical attention by calling 999 or attending Accident and Emergency is warranted if you experience severe or concerning symptoms. These include signs of severe hypoglycaemia such as confusion, difficulty speaking, loss of consciousness, seizures, or inability to swallow safely. If hypoglycaemia occurs, take 15-20g of fast-acting carbohydrate, recheck glucose after 15 minutes, and repeat if needed. Do not drive if experiencing hypoglycaemia or feeling unwell.

Persistent vomiting that prevents you from keeping down fluids for more than a few hours requires urgent assessment due to the risk of dehydration and electrolyte disturbances. Severe, unrelenting abdominal pain, particularly if it radiates to the back and is accompanied by vomiting, may indicate pancreatitis and requires immediate medical evaluation.

Signs of dehydration including reduced urine output, dark concentrated urine, dizziness on standing, dry mouth, and increased thirst should prompt urgent medical review, especially in vulnerable populations. Any symptoms of an allergic reaction, though rare, such as difficulty breathing, swelling of the face or throat, or widespread rash, constitute a medical emergency. Additionally, if you have taken significantly more than double your prescribed dose, or if a child has accidentally been exposed to Ozempic, immediate medical assessment is essential regardless of symptoms.

For ongoing monitoring after the acute period, arrange a follow-up appointment with your GP or diabetes specialist nurse within a few days to review your blood glucose control, assess for any delayed complications, and discuss strategies to prevent future dosing errors. Your healthcare team may recommend temporary adjustments to your diabetes management plan and will advise when it is safe to resume your normal Ozempic dosing schedule. Consider reporting the incident to the MHRA Yellow Card scheme to help improve medication safety.

Frequently Asked Questions